AB1 Share Price update, page-390

First 390 Last

Share
Profile

Follow
Godra

517 Posts.

47

01/12/21

07:30

Post #: 57981421
Share

Originally posted by DoubleDown!: ↑

Let's be clear here. This is NOT an AGM. At least not that I can see because I haven't received my notice of meeting yet.

There are no financial reports to pass.
There are no ratification of prior issued shares.
There is no directors report.
There are no election of directors.
There is no remuneration report.

This meeting is to simply issue Yat a whole heap of performance incentives.

Voting will be tricky to work out because half the shares on issue have not been ratified by the shareholders because there has been no AGM for three years.

There will need to be a resignation letter tendered by Grant Thornton. You can't just sack your auditor and pick a new one

This all looks very amateurish to me and Animoca better be careful because I expect ASIC to be watching very carefully. A $5bn company constantly flouting the Corp act with a lack of reporting to shareholders, holding of meetings and who knows what else won't be going unnoticed.

Expand

Can we stop with the ASIC rubbish they do nothing. If they were so good I wouldn’t have lost some cash on the scum stock BIG.

If you have a problem with Animoca’s approach ask them at the AGM. We will either see financials at the AGM or before. Exciting times and always good to keep an open mind about these things. We’re certainly moving forward.

AB1 Price at posting: 18.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

First 390 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

AB1 Share Price update, page-390

Top Stories

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Monash IVF shares cater 25% – Disaster or deep-value play?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Featured News